Related Experiment Video
Updated: Mar 22, 2026

An Optimized Hemagglutination Inhibition HI Assay to Quantify Influenza-specific Antibody Titers
Published on: December 1, 2017
Pooled influenza vaccine effectiveness estimates for Australia, 2012-2014
S G Sullivan1, K S Carville2, M Chilver3
1WHO Collaborating Centre for Reference and Research on Influenza at the Peter Doherty Institute for Infection and Immunity,Melbourne,Victoria,Australia;
This study estimated influenza vaccine effectiveness (VE) in Australia from 2012-2014. VE varied by year and influenza strain, highlighting the importance of vaccine match for public health.
Area of Science:
- Epidemiology
- Immunization
- Public Health
Background:
- Influenza remains a significant public health concern, necessitating ongoing evaluation of vaccine effectiveness.
- Sentinel surveillance networks are crucial for monitoring influenza activity and vaccine performance in real-world settings.
- Accurate estimation of influenza vaccine effectiveness (VE) is vital for informing public health policy and vaccination strategies.
Purpose of the Study:
- To estimate Australia-wide influenza vaccine effectiveness (VE) against laboratory-confirmed influenza.
- To analyze VE across different influenza seasons (2012, 2013, 2014) and circulating strains (A(H1N1)pdm09, A(H3N2), Influenza B).
- To assess the impact of pooling data from multiple surveillance networks on VE estimation precision.
Main Methods:
- Data were pooled from three Australian sentinel general practice influenza surveillance networks.
- Patients with influenza-like illness were tested for influenza; vaccination status was compared between positive and negative cases.
- Logistic regression was used to estimate VE, adjusting for age, presentation week, and surveillance network.
Main Results:
- Overall VE ranged from 38% in 2012 to 60% in 2013 and 44% in 2014.
- VE was higher in 2013 (60%) when A(H1N1)pdm09 dominated and vaccine match was good, compared to 2012 (38%) and 2014 (44%) when A(H3N2) predominated and vaccine match was poor.
- VE against Influenza B was consistently high across all years (54-57%).
Conclusions:
- Influenza vaccine effectiveness in Australia varied significantly by season, influenced by the dominant circulating strain and vaccine match.
- Pooling data from sentinel networks enhances sample size, enabling more precise subtype- and age-specific VE estimates.
- Findings underscore the importance of strain surveillance and vaccine composition for optimizing influenza vaccine effectiveness.
More Related Videos
08:52Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes
Published on: July 26, 2019
09:31Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals
Published on: April 15, 2017
Related Concept Videos
Vaccinations
Influenza